nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A2—Imiquimod—skin cancer	0.168	0.231	CbGbCtD
Dexmedetomidine—CYP1A1—Dacarbazine—skin cancer	0.158	0.217	CbGbCtD
Dexmedetomidine—CYP2E1—Dacarbazine—skin cancer	0.122	0.168	CbGbCtD
Dexmedetomidine—CYP1A2—Vemurafenib—skin cancer	0.0922	0.126	CbGbCtD
Dexmedetomidine—CYP2D6—Vemurafenib—skin cancer	0.076	0.104	CbGbCtD
Dexmedetomidine—CYP1A2—Dacarbazine—skin cancer	0.0707	0.0969	CbGbCtD
Dexmedetomidine—CYP1A2—Fluorouracil—skin cancer	0.0414	0.0568	CbGbCtD
Dexmedetomidine—Speech disorder—Temozolomide—skin cancer	0.00159	0.00588	CcSEcCtD
Dexmedetomidine—Wheezing—Bleomycin—skin cancer	0.00158	0.00582	CcSEcCtD
Dexmedetomidine—Myocardial ischaemia—Fluorouracil—skin cancer	0.00157	0.0058	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Temozolomide—skin cancer	0.00151	0.00556	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Vemurafenib—skin cancer	0.00147	0.00543	CcSEcCtD
Dexmedetomidine—Speech disorder—Fluorouracil—skin cancer	0.00147	0.00542	CcSEcCtD
Dexmedetomidine—Sweating increased—Imiquimod—skin cancer	0.0014	0.00516	CcSEcCtD
Dexmedetomidine—Respiratory failure—Temozolomide—skin cancer	0.0014	0.00515	CcSEcCtD
Dexmedetomidine—Supraventricular tachycardia—Docetaxel—skin cancer	0.00139	0.00513	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Temozolomide—skin cancer	0.00137	0.00506	CcSEcCtD
Dexmedetomidine—Pharyngolaryngeal pain—Docetaxel—skin cancer	0.00135	0.00498	CcSEcCtD
Dexmedetomidine—Leukocytosis—Fluorouracil—skin cancer	0.00134	0.00496	CcSEcCtD
Dexmedetomidine—Laryngeal pain—Docetaxel—skin cancer	0.00134	0.00494	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00134	0.00494	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Vemurafenib—skin cancer	0.00133	0.0049	CcSEcCtD
Dexmedetomidine—Haemoglobin decreased—Docetaxel—skin cancer	0.00132	0.00489	CcSEcCtD
Dexmedetomidine—Pain—Vismodegib—skin cancer	0.00132	0.00489	CcSEcCtD
Dexmedetomidine—Constipation—Vismodegib—skin cancer	0.00132	0.00489	CcSEcCtD
Dexmedetomidine—Sepsis—Dactinomycin—skin cancer	0.00132	0.00485	CcSEcCtD
Dexmedetomidine—Neuralgia—Docetaxel—skin cancer	0.00131	0.00484	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Vismodegib—skin cancer	0.00127	0.00467	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Imiquimod—skin cancer	0.00126	0.00466	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Imiquimod—skin cancer	0.00125	0.00463	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Imiquimod—skin cancer	0.00125	0.00463	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Vemurafenib—skin cancer	0.00125	0.00461	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Imiquimod—skin cancer	0.00124	0.00459	CcSEcCtD
Dexmedetomidine—Abdominal pain—Vismodegib—skin cancer	0.00122	0.00452	CcSEcCtD
Dexmedetomidine—Angiopathy—Vemurafenib—skin cancer	0.00122	0.00451	CcSEcCtD
Dexmedetomidine—Neuritis—Docetaxel—skin cancer	0.00122	0.00451	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Vemurafenib—skin cancer	0.00121	0.00448	CcSEcCtD
Dexmedetomidine—Chills—Vemurafenib—skin cancer	0.00121	0.00446	CcSEcCtD
Dexmedetomidine—Abnormal vision—Temozolomide—skin cancer	0.0012	0.00441	CcSEcCtD
Dexmedetomidine—Pleural effusion—Docetaxel—skin cancer	0.00119	0.00439	CcSEcCtD
Dexmedetomidine—Malnutrition—Vemurafenib—skin cancer	0.00117	0.00433	CcSEcCtD
Dexmedetomidine—Haemoglobin—Imiquimod—skin cancer	0.00115	0.00426	CcSEcCtD
Dexmedetomidine—Haemorrhage—Imiquimod—skin cancer	0.00115	0.00424	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.00114	0.00422	CcSEcCtD
Dexmedetomidine—Myocardial ischaemia—Docetaxel—skin cancer	0.00113	0.00419	CcSEcCtD
Dexmedetomidine—Rigors—Docetaxel—skin cancer	0.00112	0.00412	CcSEcCtD
Dexmedetomidine—Visual impairment—Imiquimod—skin cancer	0.00111	0.00409	CcSEcCtD
Dexmedetomidine—Sepsis—Fluorouracil—skin cancer	0.0011	0.00404	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vismodegib—skin cancer	0.00106	0.00391	CcSEcCtD
Dexmedetomidine—Thirst—Temozolomide—skin cancer	0.00105	0.00386	CcSEcCtD
Dexmedetomidine—Angiopathy—Imiquimod—skin cancer	0.00104	0.00385	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Imiquimod—skin cancer	0.00104	0.00382	CcSEcCtD
Dexmedetomidine—Chills—Imiquimod—skin cancer	0.00103	0.0038	CcSEcCtD
Dexmedetomidine—Arrhythmia—Imiquimod—skin cancer	0.00103	0.00379	CcSEcCtD
Dexmedetomidine—Mental disorder—Imiquimod—skin cancer	0.00101	0.00371	CcSEcCtD
Dexmedetomidine—Bronchospasm—Bleomycin—skin cancer	0.001	0.0037	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Docetaxel—skin cancer	0.001	0.0037	CcSEcCtD
Dexmedetomidine—Malnutrition—Imiquimod—skin cancer	0.001	0.00369	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.000991	0.00366	CcSEcCtD
Dexmedetomidine—Oliguria—Docetaxel—skin cancer	0.000989	0.00365	CcSEcCtD
Dexmedetomidine—Vomiting—Vismodegib—skin cancer	0.000985	0.00363	CcSEcCtD
Dexmedetomidine—Rash—Vismodegib—skin cancer	0.000977	0.0036	CcSEcCtD
Dexmedetomidine—Dermatitis—Vismodegib—skin cancer	0.000976	0.0036	CcSEcCtD
Dexmedetomidine—Infection—Vemurafenib—skin cancer	0.000951	0.00351	CcSEcCtD
Dexmedetomidine—Respiratory failure—Docetaxel—skin cancer	0.000928	0.00343	CcSEcCtD
Dexmedetomidine—Nausea—Vismodegib—skin cancer	0.00092	0.0034	CcSEcCtD
Dexmedetomidine—Agitation—Imiquimod—skin cancer	0.000919	0.00339	CcSEcCtD
Dexmedetomidine—Pneumonia—Bleomycin—skin cancer	0.000914	0.00337	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Docetaxel—skin cancer	0.000912	0.00336	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Temozolomide—skin cancer	0.000906	0.00334	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Bleomycin—skin cancer	0.000896	0.00331	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000896	0.00331	CcSEcCtD
Dexmedetomidine—Hypotension—Vemurafenib—skin cancer	0.000894	0.0033	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Bleomycin—skin cancer	0.000891	0.00329	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000878	0.00324	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Fluorouracil—skin cancer	0.000872	0.00322	CcSEcCtD
Dexmedetomidine—Convulsion—Imiquimod—skin cancer	0.000866	0.0032	CcSEcCtD
Dexmedetomidine—Abdominal distension—Temozolomide—skin cancer	0.000866	0.0032	CcSEcCtD
Dexmedetomidine—Fluid retention—Docetaxel—skin cancer	0.000866	0.00319	CcSEcCtD
Dexmedetomidine—Hypertension—Imiquimod—skin cancer	0.000863	0.00319	CcSEcCtD
Dexmedetomidine—Pneumonia—Dactinomycin—skin cancer	0.000853	0.00315	CcSEcCtD
Dexmedetomidine—Anxiety—Imiquimod—skin cancer	0.000848	0.00313	CcSEcCtD
Dexmedetomidine—Sweating increased—Temozolomide—skin cancer	0.000838	0.00309	CcSEcCtD
Dexmedetomidine—Dry mouth—Imiquimod—skin cancer	0.000833	0.00307	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000826	0.00305	CcSEcCtD
Dexmedetomidine—Haemoglobin—Bleomycin—skin cancer	0.00082	0.00303	CcSEcCtD
Dexmedetomidine—Constipation—Vemurafenib—skin cancer	0.000818	0.00302	CcSEcCtD
Dexmedetomidine—Haemorrhage—Bleomycin—skin cancer	0.000816	0.00301	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Docetaxel—skin cancer	0.000811	0.00299	CcSEcCtD
Dexmedetomidine—Infection—Imiquimod—skin cancer	0.000811	0.00299	CcSEcCtD
Dexmedetomidine—Tachycardia—Imiquimod—skin cancer	0.000797	0.00294	CcSEcCtD
Dexmedetomidine—Sepsis—Docetaxel—skin cancer	0.000791	0.00292	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Imiquimod—skin cancer	0.000789	0.00291	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Temozolomide—skin cancer	0.000776	0.00286	CcSEcCtD
Dexmedetomidine—Pneumonia—Temozolomide—skin cancer	0.000771	0.00285	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000761	0.00281	CcSEcCtD
Dexmedetomidine—Body temperature increased—Vemurafenib—skin cancer	0.000757	0.00279	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Temozolomide—skin cancer	0.000752	0.00277	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Temozolomide—skin cancer	0.000745	0.00275	CcSEcCtD
Dexmedetomidine—Chills—Bleomycin—skin cancer	0.000732	0.0027	CcSEcCtD
Dexmedetomidine—Dyspnoea—Imiquimod—skin cancer	0.000728	0.00269	CcSEcCtD
Dexmedetomidine—Somnolence—Imiquimod—skin cancer	0.000726	0.00268	CcSEcCtD
Dexmedetomidine—Pneumonia—Fluorouracil—skin cancer	0.000711	0.00262	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000705	0.0026	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Docetaxel—skin cancer	0.000698	0.00258	CcSEcCtD
Dexmedetomidine—Pain—Imiquimod—skin cancer	0.000698	0.00258	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000697	0.00257	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000693	0.00256	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Fluorouracil—skin cancer	0.000693	0.00256	CcSEcCtD
Dexmedetomidine—Haemoglobin—Temozolomide—skin cancer	0.000692	0.00255	CcSEcCtD
Dexmedetomidine—Haemorrhage—Temozolomide—skin cancer	0.000688	0.00254	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Fluorouracil—skin cancer	0.000687	0.00253	CcSEcCtD
Dexmedetomidine—Hallucination—Temozolomide—skin cancer	0.000685	0.00253	CcSEcCtD
Dexmedetomidine—Chills—Dactinomycin—skin cancer	0.000683	0.00252	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Temozolomide—skin cancer	0.000678	0.0025	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Imiquimod—skin cancer	0.000673	0.00248	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Imiquimod—skin cancer	0.000667	0.00246	CcSEcCtD
Dexmedetomidine—Visual impairment—Temozolomide—skin cancer	0.000663	0.00245	CcSEcCtD
Dexmedetomidine—Anaemia—Bleomycin—skin cancer	0.000657	0.00242	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vemurafenib—skin cancer	0.000655	0.00242	CcSEcCtD
Dexmedetomidine—Abdominal pain—Imiquimod—skin cancer	0.000645	0.00238	CcSEcCtD
Dexmedetomidine—Body temperature increased—Imiquimod—skin cancer	0.000645	0.00238	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Temozolomide—skin cancer	0.000639	0.00236	CcSEcCtD
Dexmedetomidine—Haemoglobin—Fluorouracil—skin cancer	0.000638	0.00235	CcSEcCtD
Dexmedetomidine—Haemorrhage—Fluorouracil—skin cancer	0.000634	0.00234	CcSEcCtD
Dexmedetomidine—Dizziness—Vemurafenib—skin cancer	0.000633	0.00234	CcSEcCtD
Dexmedetomidine—Angiopathy—Temozolomide—skin cancer	0.000625	0.0023	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Temozolomide—skin cancer	0.00062	0.00229	CcSEcCtD
Dexmedetomidine—Chills—Temozolomide—skin cancer	0.000618	0.00228	CcSEcCtD
Dexmedetomidine—Anaemia—Dactinomycin—skin cancer	0.000612	0.00226	CcSEcCtD
Dexmedetomidine—Vomiting—Vemurafenib—skin cancer	0.000608	0.00225	CcSEcCtD
Dexmedetomidine—Rash—Vemurafenib—skin cancer	0.000603	0.00223	CcSEcCtD
Dexmedetomidine—Mental disorder—Temozolomide—skin cancer	0.000603	0.00223	CcSEcCtD
Dexmedetomidine—Dermatitis—Vemurafenib—skin cancer	0.000603	0.00222	CcSEcCtD
Dexmedetomidine—Headache—Vemurafenib—skin cancer	0.0006	0.00221	CcSEcCtD
Dexmedetomidine—Malnutrition—Temozolomide—skin cancer	0.000599	0.00221	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000596	0.0022	CcSEcCtD
Dexmedetomidine—Confusional state—Bleomycin—skin cancer	0.000585	0.00216	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000584	0.00215	CcSEcCtD
Dexmedetomidine—Infection—Bleomycin—skin cancer	0.000576	0.00213	CcSEcCtD
Dexmedetomidine—Nausea—Vemurafenib—skin cancer	0.000568	0.0021	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Bleomycin—skin cancer	0.000568	0.00209	CcSEcCtD
Dexmedetomidine—Arrhythmia—Fluorouracil—skin cancer	0.000567	0.00209	CcSEcCtD
Dexmedetomidine—Bronchospasm—Docetaxel—skin cancer	0.000563	0.00208	CcSEcCtD
Dexmedetomidine—Diarrhoea—Imiquimod—skin cancer	0.000558	0.00206	CcSEcCtD
Dexmedetomidine—Anaemia—Temozolomide—skin cancer	0.000554	0.00204	CcSEcCtD
Dexmedetomidine—Agitation—Temozolomide—skin cancer	0.000551	0.00203	CcSEcCtD
Dexmedetomidine—Hypotension—Bleomycin—skin cancer	0.000542	0.002	CcSEcCtD
Dexmedetomidine—Dizziness—Imiquimod—skin cancer	0.00054	0.00199	CcSEcCtD
Dexmedetomidine—Infection—Dactinomycin—skin cancer	0.000537	0.00198	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dactinomycin—skin cancer	0.000529	0.00195	CcSEcCtD
Dexmedetomidine—Convulsion—Temozolomide—skin cancer	0.000519	0.00192	CcSEcCtD
Dexmedetomidine—Vomiting—Imiquimod—skin cancer	0.000519	0.00191	CcSEcCtD
Dexmedetomidine—Hypertension—Temozolomide—skin cancer	0.000517	0.00191	CcSEcCtD
Dexmedetomidine—Dyspnoea—Bleomycin—skin cancer	0.000517	0.00191	CcSEcCtD
Dexmedetomidine—Rash—Imiquimod—skin cancer	0.000515	0.0019	CcSEcCtD
Dexmedetomidine—Dermatitis—Imiquimod—skin cancer	0.000514	0.0019	CcSEcCtD
Dexmedetomidine—Pneumonia—Docetaxel—skin cancer	0.000513	0.00189	CcSEcCtD
Dexmedetomidine—Headache—Imiquimod—skin cancer	0.000511	0.00189	CcSEcCtD
Dexmedetomidine—Anaemia—Fluorouracil—skin cancer	0.00051	0.00188	CcSEcCtD
Dexmedetomidine—Anxiety—Temozolomide—skin cancer	0.000508	0.00188	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Docetaxel—skin cancer	0.000503	0.00186	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Docetaxel—skin cancer	0.0005	0.00184	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Docetaxel—skin cancer	0.0005	0.00184	CcSEcCtD
Dexmedetomidine—Dry mouth—Temozolomide—skin cancer	0.000499	0.00184	CcSEcCtD
Dexmedetomidine—Pain—Bleomycin—skin cancer	0.000496	0.00183	CcSEcCtD
Dexmedetomidine—Confusional state—Temozolomide—skin cancer	0.000493	0.00182	CcSEcCtD
Dexmedetomidine—Infection—Temozolomide—skin cancer	0.000486	0.00179	CcSEcCtD
Dexmedetomidine—Nausea—Imiquimod—skin cancer	0.000485	0.00179	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Temozolomide—skin cancer	0.000479	0.00177	CcSEcCtD
Dexmedetomidine—Convulsion—Fluorouracil—skin cancer	0.000478	0.00177	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Bleomycin—skin cancer	0.000478	0.00176	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Temozolomide—skin cancer	0.000473	0.00174	CcSEcCtD
Dexmedetomidine—Pain—Dactinomycin—skin cancer	0.000462	0.00171	CcSEcCtD
Dexmedetomidine—Haemoglobin—Docetaxel—skin cancer	0.00046	0.0017	CcSEcCtD
Dexmedetomidine—Body temperature increased—Bleomycin—skin cancer	0.000458	0.00169	CcSEcCtD
Dexmedetomidine—Haemorrhage—Docetaxel—skin cancer	0.000458	0.00169	CcSEcCtD
Dexmedetomidine—Confusional state—Fluorouracil—skin cancer	0.000454	0.00168	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Docetaxel—skin cancer	0.000451	0.00166	CcSEcCtD
Dexmedetomidine—Infection—Fluorouracil—skin cancer	0.000448	0.00165	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dactinomycin—skin cancer	0.000446	0.00164	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000442	0.00163	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Fluorouracil—skin cancer	0.000441	0.00163	CcSEcCtD
Dexmedetomidine—Visual impairment—Docetaxel—skin cancer	0.000441	0.00163	CcSEcCtD
Dexmedetomidine—Tachycardia—Fluorouracil—skin cancer	0.00044	0.00162	CcSEcCtD
Dexmedetomidine—Dyspnoea—Temozolomide—skin cancer	0.000436	0.00161	CcSEcCtD
Dexmedetomidine—Somnolence—Temozolomide—skin cancer	0.000435	0.0016	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dactinomycin—skin cancer	0.000427	0.00158	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dactinomycin—skin cancer	0.000427	0.00158	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Docetaxel—skin cancer	0.000425	0.00157	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000422	0.00156	CcSEcCtD
Dexmedetomidine—Hypotension—Fluorouracil—skin cancer	0.000421	0.00155	CcSEcCtD
Dexmedetomidine—Constipation—Temozolomide—skin cancer	0.000418	0.00154	CcSEcCtD
Dexmedetomidine—Pain—Temozolomide—skin cancer	0.000418	0.00154	CcSEcCtD
Dexmedetomidine—Angiopathy—Docetaxel—skin cancer	0.000415	0.00153	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Docetaxel—skin cancer	0.000413	0.00152	CcSEcCtD
Dexmedetomidine—Chills—Docetaxel—skin cancer	0.000411	0.00152	CcSEcCtD
Dexmedetomidine—Arrhythmia—Docetaxel—skin cancer	0.000409	0.00151	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Temozolomide—skin cancer	0.000403	0.00149	CcSEcCtD
Dexmedetomidine—Dyspnoea—Fluorouracil—skin cancer	0.000402	0.00148	CcSEcCtD
Dexmedetomidine—Mental disorder—Docetaxel—skin cancer	0.000401	0.00148	CcSEcCtD
Dexmedetomidine—Somnolence—Fluorouracil—skin cancer	0.000401	0.00148	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Temozolomide—skin cancer	0.0004	0.00148	CcSEcCtD
Dexmedetomidine—Malnutrition—Docetaxel—skin cancer	0.000399	0.00147	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000389	0.00144	CcSEcCtD
Dexmedetomidine—Body temperature increased—Temozolomide—skin cancer	0.000387	0.00143	CcSEcCtD
Dexmedetomidine—Abdominal pain—Temozolomide—skin cancer	0.000387	0.00143	CcSEcCtD
Dexmedetomidine—Pain—Fluorouracil—skin cancer	0.000385	0.00142	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Fluorouracil—skin cancer	0.000371	0.00137	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dactinomycin—skin cancer	0.00037	0.00137	CcSEcCtD
Dexmedetomidine—Vomiting—Bleomycin—skin cancer	0.000369	0.00136	CcSEcCtD
Dexmedetomidine—Anaemia—Docetaxel—skin cancer	0.000368	0.00136	CcSEcCtD
Dexmedetomidine—Rash—Bleomycin—skin cancer	0.000366	0.00135	CcSEcCtD
Dexmedetomidine—Dermatitis—Bleomycin—skin cancer	0.000365	0.00135	CcSEcCtD
Dexmedetomidine—Body temperature increased—Fluorouracil—skin cancer	0.000356	0.00131	CcSEcCtD
Dexmedetomidine—Convulsion—Docetaxel—skin cancer	0.000345	0.00127	CcSEcCtD
Dexmedetomidine—Nausea—Bleomycin—skin cancer	0.000344	0.00127	CcSEcCtD
Dexmedetomidine—Hypertension—Docetaxel—skin cancer	0.000344	0.00127	CcSEcCtD
Dexmedetomidine—Vomiting—Dactinomycin—skin cancer	0.000344	0.00127	CcSEcCtD
Dexmedetomidine—Rash—Dactinomycin—skin cancer	0.000341	0.00126	CcSEcCtD
Dexmedetomidine—Diarrhoea—Temozolomide—skin cancer	0.000335	0.00123	CcSEcCtD
Dexmedetomidine—Dry mouth—Docetaxel—skin cancer	0.000332	0.00122	CcSEcCtD
Dexmedetomidine—Confusional state—Docetaxel—skin cancer	0.000328	0.00121	CcSEcCtD
Dexmedetomidine—Dizziness—Temozolomide—skin cancer	0.000323	0.00119	CcSEcCtD
Dexmedetomidine—Infection—Docetaxel—skin cancer	0.000323	0.00119	CcSEcCtD
Dexmedetomidine—Nausea—Dactinomycin—skin cancer	0.000321	0.00119	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Docetaxel—skin cancer	0.000318	0.00118	CcSEcCtD
Dexmedetomidine—Tachycardia—Docetaxel—skin cancer	0.000317	0.00117	CcSEcCtD
Dexmedetomidine—Vomiting—Temozolomide—skin cancer	0.000311	0.00115	CcSEcCtD
Dexmedetomidine—Rash—Temozolomide—skin cancer	0.000308	0.00114	CcSEcCtD
Dexmedetomidine—Diarrhoea—Fluorouracil—skin cancer	0.000308	0.00114	CcSEcCtD
Dexmedetomidine—Dermatitis—Temozolomide—skin cancer	0.000308	0.00114	CcSEcCtD
Dexmedetomidine—Headache—Temozolomide—skin cancer	0.000306	0.00113	CcSEcCtD
Dexmedetomidine—Hypotension—Docetaxel—skin cancer	0.000304	0.00112	CcSEcCtD
Dexmedetomidine—Dizziness—Fluorouracil—skin cancer	0.000298	0.0011	CcSEcCtD
Dexmedetomidine—Nausea—Temozolomide—skin cancer	0.000291	0.00107	CcSEcCtD
Dexmedetomidine—Dyspnoea—Docetaxel—skin cancer	0.00029	0.00107	CcSEcCtD
Dexmedetomidine—Somnolence—Docetaxel—skin cancer	0.000289	0.00107	CcSEcCtD
Dexmedetomidine—Vomiting—Fluorouracil—skin cancer	0.000287	0.00106	CcSEcCtD
Dexmedetomidine—Rash—Fluorouracil—skin cancer	0.000284	0.00105	CcSEcCtD
Dexmedetomidine—Dermatitis—Fluorouracil—skin cancer	0.000284	0.00105	CcSEcCtD
Dexmedetomidine—Headache—Fluorouracil—skin cancer	0.000282	0.00104	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000281	0.00104	CcSEcCtD
Dexmedetomidine—Constipation—Docetaxel—skin cancer	0.000278	0.00103	CcSEcCtD
Dexmedetomidine—Pain—Docetaxel—skin cancer	0.000278	0.00103	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Docetaxel—skin cancer	0.000268	0.000989	CcSEcCtD
Dexmedetomidine—Nausea—Fluorouracil—skin cancer	0.000268	0.000988	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Docetaxel—skin cancer	0.000266	0.000981	CcSEcCtD
Dexmedetomidine—Abdominal pain—Docetaxel—skin cancer	0.000257	0.000949	CcSEcCtD
Dexmedetomidine—Body temperature increased—Docetaxel—skin cancer	0.000257	0.000949	CcSEcCtD
Dexmedetomidine—Diarrhoea—Docetaxel—skin cancer	0.000223	0.000821	CcSEcCtD
Dexmedetomidine—Dizziness—Docetaxel—skin cancer	0.000215	0.000794	CcSEcCtD
Dexmedetomidine—Vomiting—Docetaxel—skin cancer	0.000207	0.000763	CcSEcCtD
Dexmedetomidine—Rash—Docetaxel—skin cancer	0.000205	0.000757	CcSEcCtD
Dexmedetomidine—Dermatitis—Docetaxel—skin cancer	0.000205	0.000756	CcSEcCtD
Dexmedetomidine—Headache—Docetaxel—skin cancer	0.000204	0.000752	CcSEcCtD
Dexmedetomidine—Nausea—Docetaxel—skin cancer	0.000193	0.000713	CcSEcCtD
